Hillstream Biopharma Stock Z Score
HILSDelisted Stock | USD 0.39 0.01 2.50% |
Hillstream |
Hillstream Biopharma Company Z Score Analysis
Hillstream Biopharma's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Hillstream Biopharma Z Score | -2.34 |
Most of Hillstream Biopharma's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hillstream Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionAccording to the company's disclosures, Hillstream Biopharma has a Z Score of -2.34. This is 134.67% lower than that of the Biotechnology sector and 170.06% lower than that of the Health Care industry. The z score for all United States stocks is 126.83% higher than that of the company.
Hillstream Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hillstream Biopharma's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hillstream Biopharma could also be used in its relative valuation, which is a method of valuing Hillstream Biopharma by comparing valuation metrics of similar companies.Hillstream Biopharma is currently under evaluation in z score category among its peers.
Hillstream Fundamentals
Return On Equity | -1.47 | |||
Return On Asset | -0.78 | |||
Current Valuation | 496.66 K | |||
Shares Outstanding | 17.53 M | |||
Shares Owned By Insiders | 38.90 % | |||
Shares Owned By Institutions | 0.80 % | |||
Number Of Shares Shorted | 52.74 K | |||
Price To Book | 0.88 X | |||
EBITDA | (6.88 M) | |||
Net Income | (8.47 M) | |||
Cash And Equivalents | 9.48 M | |||
Cash Per Share | 0.82 X | |||
Total Debt | 772.9 K | |||
Current Ratio | 13.13 X | |||
Book Value Per Share | 0.18 X | |||
Cash Flow From Operations | (6.56 M) | |||
Short Ratio | 0.20 X | |||
Earnings Per Share | (0.76) X | |||
Target Price | 4.0 | |||
Market Capitalization | 4.23 M | |||
Total Asset | 6.69 M | |||
Retained Earnings | (15.38 M) | |||
Working Capital | 5.54 M | |||
Z Score | -2.34 | |||
Net Asset | 6.69 M |
About Hillstream Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hillstream Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hillstream Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hillstream Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |